Arkolith/Insider Trading/DRMA/Form 4

Hale David F

Director, 10% OwnerDermata Therapeutics, Inc. (DRMA) · full profile →Form 4 · filed Aug 17, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
6 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2021Conversion(C)45K——299K
Aug 17, 2021Conversion(C)12K——312K
Aug 17, 2021Buy(P)36K——36K
Aug 17, 2021Conversion(C)174K——506K
Aug 17, 2021Conversion(C)27K——533K
Aug 17, 2021Conversion(C)20K——332K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 17, 2021Conversion(C)302K—$00
Aug 17, 2021Conversion(C)250K—$00
Aug 17, 2021Conversion(C)410K—$00
Aug 17, 2021Conversion(C)3.6M—$00
Aug 17, 2021Buy(P)36K——36K
Aug 17, 2021Conversion(C)63K—$00
Aug 17, 2021Conversion(C)3K—$03K
Aug 17, 2021Conversion(C)556K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-001110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Dermata Therapeutics, Inc.

Build

Ask your agent about DRMA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000905718-21-001110"
Ask your agent
Use Arkolith to summarize insider buying and selling at Dermata Therapeutics, Inc.
over the last 90 days and cite the filings.